Skip to main content

Bio-Rad Opens European headquarters in Basel, Switzerland, in April 2017

| News

Bio-Rad Opens European headquarters in Basel, Switzerland, in April 2017

12.04.2017

In April, Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products opened a facility in Basel, Switzerland. The new site will serve as a European headquarters for the company with administration offices and other areas that include research and development, purchasing, sales, and distribution. Bio-Rad was founded in 1952 and is based in Hercules, California, and has offices and facilities around the world. In 2017, embarking on its 65th year of operation, Bio-Rad’s global network of over 8,250 employees and operations are helping people live longer, healthier lives.

(img: Bio-Rad)

The California-based company is joining a growing number of US biotech companies such as Ultragenyx, Roivant Sciences and Singulex that have recently opened their European and global headquarters in Basel, Switzerland.

Bio-Rad is among the top five life science companies in the world, providing instruments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. The company’s products and solutions are based on technologies to separate, purify, identify, analyze, and amplify biological materials such as antibodies, proteins, nucleic acids, cells, and bacteria.

As a leading global provider of in-vitro diagnostics supplies, Bio-Rad’s diagnostic products and systems leverage a broad range of technologies and deliver high-value clinical information in the blood transfusion, diabetes monitoring, autoimmune, and infectious disease testing markets. These products are used to support the diagnosis, monitoring, and treatment of diseases and other medical conditions.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.